- Home
- EWCZ vs NKTR Comparison
EWCZ vs NKTR Comparison
Compare EWCZ & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- NKTR
- Stock Information
- Founded
- EWCZ 2004
- NKTR 1990
- Country
- EWCZ United States
- NKTR United States
- Employees
- EWCZ N/A
- NKTR N/A
- Industry
- EWCZ Package Goods/Cosmetics
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- EWCZ Consumer Discretionary
- NKTR Health Care
- Exchange
- EWCZ Nasdaq
- NKTR Nasdaq
- Market Cap
- EWCZ 146.9M
- NKTR 160.4M
- IPO Year
- EWCZ 2021
- NKTR 1994
- Fundamental
- Price
- EWCZ $3.57
- NKTR $0.59
- Analyst Decision
- EWCZ Buy
- NKTR Strong Buy
- Analyst Count
- EWCZ 7
- NKTR 6
- Target Price
- EWCZ $5.64
- NKTR $4.92
- AVG Volume (30 Days)
- EWCZ 773.2K
- NKTR 2.3M
- Earning Date
- EWCZ 05-14-2025
- NKTR 05-08-2025
- Dividend Yield
- EWCZ N/A
- NKTR N/A
- EPS Growth
- EWCZ 29.60
- NKTR N/A
- EPS
- EWCZ 0.22
- NKTR N/A
- Revenue
- EWCZ $216,916,000.00
- NKTR $87,248,000.00
- Revenue This Year
- EWCZ N/A
- NKTR N/A
- Revenue Next Year
- EWCZ $2.69
- NKTR N/A
- P/E Ratio
- EWCZ $16.18
- NKTR N/A
- Revenue Growth
- EWCZ N/A
- NKTR N/A
- 52 Week Low
- EWCZ $2.72
- NKTR $0.43
- 52 Week High
- EWCZ $12.05
- NKTR $1.93
- Technical
- Relative Strength Index (RSI)
- EWCZ 50.91
- NKTR 39.04
- Support Level
- EWCZ $3.12
- NKTR $0.57
- Resistance Level
- EWCZ $3.42
- NKTR $0.81
- Average True Range (ATR)
- EWCZ 0.21
- NKTR 0.06
- MACD
- EWCZ 0.11
- NKTR -0.01
- Stochastic Oscillator
- EWCZ 85.52
- NKTR 7.48
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.